1. Home
  2. GRBK vs HCM Comparison

GRBK vs HCM Comparison

Compare GRBK & HCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GRBK
  • HCM
  • Stock Information
  • Founded
  • GRBK N/A
  • HCM 2000
  • Country
  • GRBK United States
  • HCM Hong Kong
  • Employees
  • GRBK N/A
  • HCM N/A
  • Industry
  • GRBK Homebuilding
  • HCM Biotechnology: Pharmaceutical Preparations
  • Sector
  • GRBK Consumer Discretionary
  • HCM Health Care
  • Exchange
  • GRBK Nasdaq
  • HCM Nasdaq
  • Market Cap
  • GRBK 2.9B
  • HCM 2.5B
  • IPO Year
  • GRBK N/A
  • HCM N/A
  • Fundamental
  • Price
  • GRBK $65.14
  • HCM $15.03
  • Analyst Decision
  • GRBK Buy
  • HCM Strong Buy
  • Analyst Count
  • GRBK 2
  • HCM 1
  • Target Price
  • GRBK $71.00
  • HCM $28.00
  • AVG Volume (30 Days)
  • GRBK 264.2K
  • HCM 37.6K
  • Earning Date
  • GRBK 07-30-2025
  • HCM 08-07-2025
  • Dividend Yield
  • GRBK N/A
  • HCM N/A
  • EPS Growth
  • GRBK 7.68
  • HCM N/A
  • EPS
  • GRBK 7.83
  • HCM 0.53
  • Revenue
  • GRBK $2,137,742,000.00
  • HCM $602,197,000.00
  • Revenue This Year
  • GRBK N/A
  • HCM $15.00
  • Revenue Next Year
  • GRBK $12.17
  • HCM $19.91
  • P/E Ratio
  • GRBK $8.23
  • HCM $6.03
  • Revenue Growth
  • GRBK 13.87
  • HCM N/A
  • 52 Week Low
  • GRBK $50.57
  • HCM $11.51
  • 52 Week High
  • GRBK $84.66
  • HCM $21.50
  • Technical
  • Relative Strength Index (RSI)
  • GRBK 50.71
  • HCM 36.04
  • Support Level
  • GRBK $64.29
  • HCM $16.91
  • Resistance Level
  • GRBK $66.60
  • HCM $18.17
  • Average True Range (ATR)
  • GRBK 1.79
  • HCM 0.49
  • MACD
  • GRBK -0.19
  • HCM -0.32
  • Stochastic Oscillator
  • GRBK 54.87
  • HCM 4.89

About GRBK Green Brick Partners Inc.

Green Brick Partners Inc is a homebuilding and land development company. It acquires and develops land, as well as provides land and construction financing to its controlled builders. The company has three reportable segments: builder operations central, builder operations southeast, and land development. The majority of the company's revenue is generated from the builder operations central segment which is entirely the operations of builders in Texas. The company is engaged in various aspects of the homebuilding process, including land acquisition and development, entitlements, design, construction, marketing, sales, and brand image creation. In addition to homebuilding, the company provides home financing services, such as mortgage and title.

About HCM HUTCHMED (China) Limited

HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.

Share on Social Networks: